当前位置: X-MOL 学术 › Human Psychopharmacology: Clinical and Experimental › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Association of ANKK1 polymorphism with antipsychotic-induced hyperprolactinemia.
Human Psychopharmacology: Clinical and Experimental ( IF 1.672 ) Pub Date : 2020-05-08 , DOI: 10.1002/hup.2737
Olga Yu Fedorenko 1, 2 , Diana Z Paderina 1, 3 , Anton J M Loonen 4, 5 , Ivan V Pozhidaev 1, 3 , Anastasiia S Boiko 1 , Elena G Kornetova 1, 6 , Nikolay A Bokhan 1, 7, 8 , Bob Wilffert 4, 9 , Svetlana A Ivanova 1, 2, 8
Affiliation  

Schizophrenia is a severe highly heritable mental disorder. Genetic polymorphisms of dopaminergic pathways are related to pathogenesis of drug response. Hyperprolactinemia (HPRL), a common adverse effect of antipsychotics, is attributed to blockade of dopamine D2 receptors. Ankyrin Repeat and Kinase Domain containing 1 (ANKK1 ) gene is closely related to Dopamine Receptor D2 type (DRD2 ) gene functioning. We examined whether the functional polymorphism rs2734849 in the ANKK1 gene is associated with antipsychotic‐induced HPRL.

中文翻译:

ANKK1基因多态性与抗精神病药诱发的高泌乳素血症的关联。

精神分裂症是一种严重的高度遗传性精神障碍。多巴胺能途径的遗传多态性与药物反应的发病机制有关。高泌乳素血症(HPRL)是抗精神病药的常见不良反应,归因于多巴胺D2受体的阻滞。包含1(ANKK1)基因的锚蛋白重复和激酶结构域与多巴胺受体D2型(DRD2)基因的功能密切相关。我们检查了ANKK1基因中的功能性多态性rs2734849是否与抗精神病药诱发的HPRL相关。
更新日期:2020-07-16
down
wechat
bug